-
Deidentified Individual Participant Data Set (IPD)
-
Yes - There is a plan to make this available
-
Study Protocol
-
Yes - There is a plan to make this available
-
Statistical Analysis Plan
-
Yes - There is a plan to make this available
-
Informed Consent Form
-
Yes - There is a plan to make this available
-
Clinical Study Report
-
Yes - There is a plan to make this available
-
Analytic Code
-
Yes - There is a plan to make this available
-
Data Dictionary
-
Yes - There is a plan to make this available
-
Title and more details about the data/document
-
De-identified individual participant dataset containing baseline demographic characteristics, procedural sedation efficacy outcomes based on the Pediatric Sedation State Scale, hemodynamic parameters, sedation and recovery durations, and adverse event profiles; alongside the full study protocol, statistical analysis plan, analytic codes, and data dictionary.
-
When the data will become available and for how long
-
Beginning 6 months following the official publication of the primary trial results in a peer-reviewed scientific journal, and remaining accessible for a duration of 5 years.
-
To whom data/document is available
-
Qualified academic researchers, clinical investigators, and biostatisticians affiliated with recognized academic or research institutions.
-
Under which criteria data/document could be used
-
Exclusively for non-commercial, scientifically valid research purposes, systematic reviews, or meta-analyses, governed by an approved study proposal and the execution of a formal data use and confidentiality agreement.
-
From where data/document is obtainable
-
Directly obtainable upon formal written request directed to the corresponding author’s institutional email address.
-
What processes are involved for a request to access data/document
-
Interested researchers must submit a formal request comprising a brief research proposal, statistical analysis outline, and institutional ethics approval to the corresponding author. Following methodological review and approval by the principal investigator, a formal Data Use Agreement is signed, and the de-identified data files are securely transferred.
-
Comments
-
All shared data are strictly de-identified with no direct patient identifiers, ensuring that participant privacy and confidentiality are fully protected in compliance with research ethics principles and the International Committee of Medical Journal Editors standards.